A mutation in the KCNJ2 gene has also been shown to cause short QT syndrome.
Kir2.1 impairment has been linked to endothelial dysfunction in metabolic disease. This is thought to be due in part to impairment of the channel by fatty acids.
In research
In neurogenetics, Kir2.1 is used in Drosophila research to inhibit neurons, as overexpression of this channel will hyperpolarize cells.
In optogenetics, a trafficking sequence from Kir2.1 has been added to halorhodopsin to improve its membrane localization. The resulting protein eNpHR3.0 is used in optogenetic research to inhibit neurons with light.